T-cell proliferative response is controlled by loci Tria4 and Tria5 on mouse chromosomes 7 and 9

Mammalian Genome

Volumn 10, Issue 7, 1999, Pages 670-674

  Havelková, Helona ^a   Kosařová, Marcela ^a   Krulová, Magdalena ^a   Demant, Peter ^b   Lipoldová, Marie ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; FC RECEPTOR;

ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 7; CHROMOSOME 9; CONTROLLED STUDY; GENE LOCUS; GENE MAPPING; GENETIC REGULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; REGULATORY MECHANISM; STRAIN DIFFERENCE;

ANIMALS; CELL DIVISION; CHROMOSOME MAPPING; FEMALE; LINKAGE (GENETICS); MALE; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES;

RODENTIA;

EID: 0032816174     PISSN: 09388990     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003359901069     Document Type: Article

References (34)

1. Cantrell D (1996) T cell antigen receptor signal transduction pathways. Annu Rev Immunol 14, 259-274
2. Chang AE, Aruga A, Cameron MJ, Sondak VK, Normolle DP et al. (1997) Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2. J Clin Oncol 15, 796-807
3. Demant P (1992) Genetic resolution of susceptibility to cancer - new perspectives. Semin Cancer Biol 3, 159-166
4. Demant P, Hart AAM (1986) Recombinant congenic strains: a new tool for analyzing genetic traits determined by more than one gene. Immunogenetics 24, 416-422
5. Demant P, Lipoldová M, Svobodová M (1996) Resistance to Leishmania major in mice [Technical comment]. Science 274, 1392
6. Dietrich W, Katz H, Lincoln SE, Shin H-S, Friedman J et al. (1992) A genetic map of the mouse suitable for typing interspecific crosses. Genetics 131, 423-447
7. Djeha A, Pérez-Arellano JL, Hayes SL, Brock JH (1992) Transferrin synthesis by macrophages: up-regulation by gamma-interferon and effect on lymphocyte proliferation. FEMS Microbiol Immunol 5, 279-282
8. Fijneman RJA, Ophoff RA, Hart AAM, Demant P (1994) Kras-2 alleles, mutations, and lung tumor susceptibility in the mouse - an evaluation. Oncogene 9, 1417-1421
9. Fijneman RJA, de Vries SS, Jansen RC, Demant P (1996) Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence susceptibility to lung cancer in the mouse. Nat Genet 14, 465-467
10. Haagen IA (1995) Performance of CD3×CD19 bispecific monoclonal antibodies in B cell malignancy. Leuk Lymphoma 19, 381-393
11. Havelková H, Krulová M, Kosařová M, Holáň V, Hart AAM et al. (1996) Genetic control of T-cell proliferative response in mice linked to chromosomes 11 and 15. Immunogenetics 44, 475-477
12. Havelková H, Kosařová M, Krulová M, Holáň V, Demant P et al. (1999) T-cell proliferative response is controlled by locus Tria3 on mouse chromosome 17. Immunogenetics 49, 235-237
13. Hibbs ML, Hogart PM, McKenzie IFC (1985) The mouse Ly-17 locus identifies a polymorphism of the Fe receptor. Immunogenetics 22, 335-348
14. Holáň V, Lipoldová M, Demant P (1996) Identical genetic control of MLC reactivity to different MHC incompatibilities, independent of production and response to IL-2. Immunogenetics 44, 27-35
15. Jenkins MK, Johnson JG (1993) Molecules involved in T-cell costimulation. Curr Opin Immunol 5, 361-367
16. Kosařová M, Havelková H, Krulová M, Demant P, Lipoldová M (1999) The production of two Th2 cytokines, interleukin-4 and interleukin-10, is controlled independently by locus Cypr1 and by loci Cypr2 and Cypr3, respectively. Immunogenetics 49, 134-141
17. Krulová M, Havelková H, Kosařová M, Holáň V, Hart AAM et al. (1997) IL-2-induced proliferative response is controlled by loci Cinda1 and Cinda2 on mouse chromosomes 11 and 12: a distinct control of the response induced by different IL-2 concentrations. Genomics 42, 11-15
18. Laird P, Zijderveld A, Linders K, Rudnicky MA, Jaenisch R (1991) Simplified mammalian DNA isolation procedure. Nucleic Acids Res 19, 4293
19. Lander ES, Schork NJ (1994) Genetic dissection of complex traits. Science 265, 2037-2048
20. Lee GH, Benett LM, Carabeo RA, Drinkwater NR (1995) Identification of hepatocarcinogen-resistance genes in DBA/2 mice. Genetics 193, 387-395
21. Lipoldová M, Kosařová M, Zajfcová H, Holáň V, Hart AAM et al. (1995) Separation of multiple genes controlling the T-cell proliferative response to IL-2 and anti-CD3 using recombinant congenic strains. Immunogenetics 41, 301-311
22. Moen CJA, van der Valk MA, Snoek M, van Zutphen LFM, von Deimling O et al. (1991) The recombinant congenic strains: a novel genetic tool applied to the study of colon tumor development in the mouse. Mamm Genome 1, 217-227
23. Moen CJA, Groot PC, Hart AAM, Snoek M, Demant P (1996) Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer. Proc Natl Acad Sci USA 93, 1082-1086
24. Ohashi Y, Tachibana K, Kamiguchi K, Fujita H, Morimoto C (1998) T cell receptor-mediated tyrosine phosphorylation of Cas-L, a 105-kDa Crk-associated substrate-related protein, and its association of Crk and C3G. J Biol Chem 273, 6446-6451
25. Shreffler DC (1960) Genetic control of serum transferrin in mice. Proc Natl Acad Sci USA 46, 1378-1384
26. Smith SL (1996) Ten years of Orthoclone OKT3 (muromonab-CD3): a review. J Transpl Coord 6, 109-119
27. Stassen APM, Groot PC, Eppig JT, Demant P (1996) Genetic composition of the recombinant congenic strains. Mamm Genome 7, 55-58
28. Tax WJM, Willelms HW, Reekers PPM, Capel PJA, Koene RAP (1983) Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells. Nature 304, 445-447
29. Tibben JG, Boerman OC, Massuger LF, Schijf CP, Claessens RA et al. (1996) Pharmacokinetics, biodistribution and biological effects of intravenously administered monoclonal antibody OC/TR F(ab')2 in ovarian carcinoma patients. Int J Cancer 66, 477-483
30. Tomonari K (1988) A rat antibody against a structure functionally related to the mouse T-cell receptor/T3 complex. Immunogenetics 28, 455-458
31. Wezel T, Stassen APM, Moen CJA, Hart AAM, van der Valk MA et al. (1996) Gene interaction and single gene effects in colon tumor susceptibility in mice. Nat Genet 14, 468-470
32. Waid TH, Lucas BA, Thompson JS, McKeown JW, Brown S et al. (1997) Treatment of renal allograft rejection with T10.B9.IA31 or OKT3: final analysis of a phase II clinical trial. Transplantation 64, 274-281
33. Wange RL, Samelson LE (1996) Complex complexes: signaling at the TCR. Immunity 5, 197-205
34. Ward ES, Quadri A (1997) Biophysical and structural studies of TCRs and ligands: implications for T cell signaling. Curr Opin Immunol 9, 97-106